Work

Abstract CT242: Phase 2b study of alloHSCT patients receiving RGI-2001, an NKT cell activator, demonstrates safety and protection from acute GVHD, correlating with increased NKT cell number in patient blood

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2024-ct242

Authors: Jack D. Bui, Calvin Lee, Christine Caron, Dana Lee, Zachariah DeFilipp, Yi-Bin Chen

Institutions: University of California San Diego, Massachusetts General Hospital

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4393988738

Cites:

Cited by:

Related to: 10